ArticleDrug design, development and therapy2022

Erratum: Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer [Corrigendum].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.